Listar MED_Articles por autoría "2c8a5605-0f25-4f5b-9650-2829aa78aee9"
Mostrando ítems 1-15 de 15
-
Beta‐blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve‐HR trial)
Palau, Patricia; Seller, Julia; Domínguez Mafé, Eloy; Gómez, Inés; Ramón, José María; Sastre, Clara; De la Espriella, Rafael; Santas, Enrique; Miñana, Gema; Chorro, Francisco J.; González Juanatey, José Ramón; Nuñez, Julio Wiley (2020)Background: The pathophysiology of heart failure with preserved ejection fraction (HFpEF) is complex and multifactorial. Chronotropic incompetence (ChI) has emerged as a crucial pathophysiological mechanism. Beta‐blockers, ... -
Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design
Miñana, Gema; Cardells, Ingrid; Palau, Patricia; Llàcer, Pau; Facila Rubio, Lorenzo; Almenar, Luis; López‐Lereu, Maria Pilar; Monmeneu, Jose V.; Amiguet, Martina; González, Jessika; Serrano, Alicia; Montagud, Vicente; López‐Vilella, Raquel; Valero, Ernesto; García-Blas, Sergio; Bodí, Vicent; De la Espriella, Rafael; Sanchis, Juan; Chorro, Francisco J.; Bayes-Genis, Antoni; Núñez, Julio; Myocardial‐IRON Investigators Wiley (2018)Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for ... -
Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction
Palau, Patricia; Domínguez Mafé, Eloy; Seller, Julia; Sastre, Clara; Sanchis, Juan; López, Laura; Bodí, Vicent; Llàcer, Pau; Miñana, Gema; De la Espriella, Rafael; Bayes-Genis, Antoni; Núñez, Julio Elsevier (2022)Introduction and objectives: Little is known about the usefulness of heart rate (HR) response to exercise for risk stratification in heart failure with preserved ejection fraction (HFpEF). Therefore, this study aimed ... -
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction
Amiguet, Martina; Palau, Patricia; Domínguez Mafé, Eloy; Seller, Julia; GARCIA-PINILLA, JOSE MANUEL; De la Espriella, Rafael; Miñana, Gema; Valle, Alfonso; Sanchis, Juan; Górriz, José Luis; Bayes-Genis, Antoni; DAPA-VO2 Investigators, /; Núñez, Julio Nature Research (2023)Circulating antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload in heart failure. This study aimed to evaluate the effect of dapagliflozin on short-term CA125 levels in patients with stable heart ... -
Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction
Palau, Patricia; Bertomeu-González, Vicente; Sanchis, Juan; Soler Costa, Meritxell; De la Espriella, Rafael; Domínguez Mafé, Eloy; Santas, Enrique; Núñez, Eduardo; Chorro, Francisco J.; Miñana, Gema; Bayes-Genis, Antoni; Núñez, Julio Elsevier (2019)Introduction and objectives Type 2 diabetes mellitus (DM2) is a common comorbidity in patients with heart failure (HF) with preserved ejection fraction (HFpEF). Previous studies have shown that diabetic women are at ... -
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction
Miñana, Gema; De la Espriella, Rafael; Palau, Patricia; Amiguet Comins, Martina; Seller, Julia; García Pinilla, José Manuel; Núñez, Eduardo; Górriz, José Luis; Valle, Alfonso; Sanchis, Juan; Bayés-Genís, Antoni; Núñez, Julio; DAPA-VO2 Investigators, / Elsevier (2023)Introduction and objectives Sodium-glucose cotransporter-2 inhibitors (SGLT2i) induce short-term changes in renal function and hemoglobin. Their pathophysiology is incompletely understood. We aimed to evaluate the ... -
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction
Palau, Patricia; Seller, Julia; Domínguez Mafé, Eloy; Sastre, Clara; Ramón, Jose María; De la Espriella, Rafael; Santas, Enrique; Miñana, Gema; Bodí, Vicent; Sanchis, Juan; Valle, Alfonso; Chorro, F. Javier; Llácer, Pau; Bayes-Genis, Antoni; Núñez, Julio Elsevier (2021-11-15)BACKGROUND Chronotropic incompetence has shown to be associated with a decrease in exercise capacity in heart failure with preserved ejection fraction (HFpEF), yet b-blockers are commonly used in HFpEF despite the lack ... -
Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial
Palau, Patricia; López, Laura; Domínguez, Eloy; De la Espriella, Rafael; Campuzano, Raquel; Castro, Almudena; Miñana, Gema; Fernández-Cisnal, Agustín; Sanchis, Juan; Núñez, Julio Wiley Open Access (2024-01-15)Background Iron deficiency (ID) is associated with impaired functional capacity in patients with heart failure (HF), even in those with preserved ejection fraction (HFpEF). This study aimed to evaluate the effect of ... -
Iron deficiency and short-term adverse events in patients with decompensated heart failure
Palau, Patricia; Llàcer, Pau; Domínguez Mafé, Eloy; Tormo, Juan Pablo; Zakarne, Rim; Mollar, Anna; Martínez, Ana; Miñana, Gema; Santas, Enrique; Almenar-Bonet, Luis; Fácila, Lorenzo; De la Espriella, Rafael; Núñez, Eduardo; Manzano, Luis; Bayes-Genis, Antoni; Núñez, Julio Springer (2021-03-15)Background: For patients with heart failure (HF), iron deficiency (ID) is a common therapeutic target. However, little is known about the utility of transferrin saturation (TSAT) or serum ferritin for risk stratification ... -
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial
Núñez, Julio; Miñana, Gema; Cardells, Ingrid; Palau, Patricia; Llàcer, Pau; Facila Rubio, Lorenzo; Almenar-Bonet, Luis; Lopez-Lereu, Maria Pilar; Monmeneu Menadas, Jose Vicente; Amiguet Comins, Martina; González, Jessika; Serrano, Alicia; Montagud, Vicente; López‐Vilella, Raquel; Valero, Ernesto; García-Blas, Sergio; Bodí, Vicent; De la Espriella, Rafael; Lupón, Josep; Navarro, Jorge; Górriz, José Luis; Sanchis, Juan American Heart Association (2020-02-13)Background Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. The ... -
Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction
Santas, Enrique; De la Espriella, Rafael; Palau, Patricia; Miñana, Gema; Amiguet Comins, Martina; Sanchis, Juan; Lupón, Josep; Bayes-Genis, Antoni; Chorro, Francisco J.; Núñez, Julio Wiley (2020-03-25)Aims Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) ... -
Right Ventricular Dysfunction Staging System for Mortality Risk Stratifiction in Heart Failure with Preserved Ejection Fraction
Santas, Enrique; De la Espriella, Rafael; Chorro, Francisco J.; Palau, Patricia; Miñana, Gema; Heredia, Raquel; Amiguet Comins, Martina; Merenciano Gonzalez, Hector; Sanchis, Juan; Lupón, Josep; Bayes-Genis, Antoni; Núñez, Julio MDPI (2020-03-18)Right ventricular dysfunction (RVD) parameters are increasingly important features in heart failure with preserved ejection fraction (HFpEF). We sought to evaluate the prognostic impact of a progressive RVD staging system ... -
Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction
Lorenzo, Miguel; Miñana, Gema; Palau, Patricia; Amiguet, Martina; Seller, Julia; García Pinilla, José Manuel; Villar, Sandra; De la Espriella, Rafael; Núñez, Eduardo; Górriz, José Luis; Valle, Alfonso; Bodí, Vicent; Sanchis, Juan; Bayes-Genis, Antoni; Núñez, Julio; DAPA-VO2 Investigators Elsevier (2023-05)Background: We aimed to evaluate the effect of dapagliflozin on short-term changes in hemoglobin in patients with stable heart failure with reduced ejection fraction (HFrEF) and whether these changes mediated the effect ... -
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial
Palau, Patricia; Amiguet Comins, Martina; Domínguez Mafé, Eloy; Sastre, Clara; Mollar, Anna; Seller, Julia; GARCIA-PINILLA, JOSE MANUEL; Larumbe, Ainoha; Valle, Alfonso; Gómez Doblas, Juan José; De la Espriella, Rafael; Miñana, Gema; Robles Mezcua, Ainhoa; Santas, Enrique; Bodí, Vicent; Sanchis, Juan; Pascual-Figal, Domingo A.; Gorriz, Jose Luis; Bayes-Genis, Antoni; Núñez, Julio Wiley (2022-05-23)Aims This study aimed to evaluate the effect of dapagliflozin on 1 and 3-month maximal functional capacity in patients with stable heart failure with reduced ejection fraction (HFrEF). Methods and results In this ... -
Usefulness of Right Ventricular to Pulmonary Circulation Coupling as an Indicator of Risk for Recurrent Admissions in Heart Failure With Preserved Ejection Fraction
Santas, Enrique; Palau, Patricia; Guazzi, Marco; De la Espriella, Rafael; Miñana, Gema; Sanchis, Juan; Bayes-Genis, Antoni; Lupón, Josep; Chorro, Francisco J.; Núñez, Julio Elsevier (2019)In recent years, the study of right ventricular (RV) to pulmonary circulation (PC) coupling in heart failure with preserved ejection fraction (HFpEF) has been a matter of special interest. Tricuspid annular plane systolic ...